ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI

April 19, 1985

President Asks ‘Standstill’ FY 1976 Budget For NCI, $123 Million Slash From ’75 Spending

February 7, 1975

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

NCAB Committee Approves Staff Plan For New Comprehensive Cancer Center Grant Mechanism

April 29, 1988

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976